Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Marketers shift growing shares of search spending to GEO
Generative AI is pushing brands to shift SEO budgets toward visibility in AI-generated answers over clicks.
Philadelphia Cream Cheese pulls dollars from search – people aren’t Googling ‘cream cheese’
Philadelphia Cream Cheese has stopped paying for search ads, at least to prospective shoppers on Google. Over the past year, the Kraft Heinz-owned CPG brand has phased out its traditional search ad spend, opting to put those dollars instead into retail media and broader channels, according to Maddy Zingle, vp of marketing for Philadelphia Cream […]
TikTok courts CMOs with first-ever Collective, as it targets bigger budgets
In its first CMO-focused event in the U.K. TikTok showcased how easy it is for brands to create content. The event is only part of the platform’s sharper 2026 commercial strategy: targeting larger, long-term ad budgets, courting independent agencies, and positioning itself as a serious competitor to Meta in 2026.